XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 3,546 $ 2,772 $ 10,647 $ 13,077
General and administrative 2,190 2,061 7,385 20,679
Total operating expenses 5,736 4,833 18,032 33,756
Loss from operations (5,736) (4,833) (18,032) (33,756)
Change in fair value of financial instruments (100) 0 7,790 3,168
Other income 218 214 800 377
Total other income 118 214 8,590 3,545
Net loss $ (5,618) $ (4,619) $ (9,442) $ (30,211)
Net loss per share - basic $ (0.5) $ (0.82) $ (0.88) $ (7.43)
Net loss per share - diluted $ (0.5) $ (0.82) $ (0.88) $ (7.43)
Weighted-average number of shares outstanding used in computing net loss per share - basic 11,134,964 5,667,343 10,674,531 4,068,526
Weighted-average number of shares outstanding used in computing net loss per share - diluted 11,134,964 5,667,343 10,674,531 4,068,526